Biocon Biologics, a subsidiary of Biocon, and Viatris Inc. confirmed that Insulin Glargine (insulin glargine-yfgn) injection will be offered through the Walgreens Prescription Savings Club, saving members up to 80 percent off the cash price of comparable long-acting insulins purchased at Walgreens.
This decision by Walgreens follows the launch of Insulin Glargine (insulin glargine-yfgn) announced on 16 November. Biocon Biologics and Viatris co-developed the product, and together the companies are committed to improving patients' access to sustainable, quality and more affordable healthcare.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
